Eleonora Magistrelli
Forli, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Association Between Severity of COVID-19 Respiratory Disease and Risk of Obstructive Sleep Apnea.
Journal: Ear, nose, & throat journal
Published: July 28, 2021
Substitution of nevirapine or raltegravir for protease inhibitor vs. rosuvastatin treatment for the management of dyslipidaemia in HIV-infected patients on stable antiretroviral therapy (Nevrast study).
Journal: Infectious diseases (London, England)
Published: July 08, 2017
Prevalence of metabolic syndrome in HIV-infected patients naive to antiretroviral therapy or receiving a first-line treatment.
Journal: HIV clinical trials
Published: April 20, 2017
Dual Raltegravir-Etravirine Combination as Maintenance Regimen in Virologically Suppressed HIV-1-Infected Patients.
Journal: AIDS research and human retroviruses
Published: January 17, 2017
Significant Decrease in Plasma Levels of D-Dimer, Interleukin-8, and Interleukin-12 After a 12-Month Treatment with Rosuvastatin in HIV-Infected Patients Under Antiretroviral Therapy.
Journal: AIDS research and human retroviruses
Published: September 13, 2016
No correlation between statin exposure and incident diabetes mellitus in HIV-1-infected patients receiving combination antiretroviral therapy.
Journal: HIV medicine
Published: December 10, 2015
Improvement in renal function and bone mineral density after a switch from tenofovir/emtricitabine plus ritonavir-boosted protease inhibitor to raltegravir plus nevirapine: a pilot study.
Journal: Antiviral therapy
Published: September 21, 2015
Plasma concentrations of efavirenz, darunavir/ritonavir and raltegravir in HIV-HCV-coinfected patients without liver cirrhosis in comparison with HIV-monoinfected patients.
Journal: Infectious diseases (London, England)
Published: April 16, 2015
Last Updated: 09/26/2026